Food Noise, Mood, and the Quiet Months

This is the part of treatment that gets least clinical attention and comes up most often in the room, so it is worth writing down properly.

Food noise, and what it actually is

“Food noise” is not a technical term and it describes something real: the continuous background negotiation about eating. Planning lunch during breakfast. The argument about the biscuit that runs for twenty minutes and that you sometimes lose. The low-grade preoccupation that occupies a portion of your attention every day, for years.

For a lot of people on these drugs it simply stops, often within the first weeks, and they describe that as the most significant thing that happened — more significant than the weight.

It is distinct from appetite suppression. Hunger is a physiological signal. Food noise is cognitive, and it is why people who never described themselves as especially hungry still notice the silence. GLP-1 receptors are present in brain regions involved in reward and motivation, which makes the effect unsurprising in retrospect. The alcohol craving findings look like the same mechanism pointed at a different target.

The relief is genuine and it deserves to be named rather than treated as a side note.

What arrives later

Around 3–5 months in, a meaningful number of people describe something harder to articulate. Flatness. Less to look forward to. A day that is fine and slightly grey.

Several things plausibly contribute, and I would not pretend to know the proportions.

Food was doing work. For many people it was a reliable, available pleasure and a reliable way of managing a difficult evening. Removing it removes a coping mechanism, and nothing automatically arrives to replace it. That is a real loss and it is not irrational to feel it.

Sustained low intake affects mood. Eating 800 calories a day for 6 months is not neutral, and a 30–50% drop in intake takes iron, B12 and protein down with it. Under-eating protein, running low on iron or B12, and being mildly dehydrated all show up as flatness — which is why the first thing I check is whether someone is actually eating enough, not whether they need an antidepressant. Reading your own labs covers what to measure.

Rapid physical change is destabilising, even when it is wanted. People treat you differently. Clothes, photographs and mirrors stop matching your internal model. A body you had complicated feelings about is now a body you have different complicated feelings about.

And the reward circuitry is being acted upon directly. Whether the drug blunts non-food pleasures in some people is not settled. I am not going to assert it and I am not going to dismiss it.

The suicidality question, answered properly

This deserves a straight answer because the coverage was frightening and the resolution got much less attention than the alarm.

After case reports of suicidal ideation, both the FDA and the European Medicines Agency reviewed the available data. Neither found evidence supporting a causal link between GLP-1 receptor agonists and suicidal thoughts or behaviour, and large observational analyses have not shown an increased risk — some have suggested the opposite direction.

That is real reassurance about causation, and it is where the evidence currently sits.

What it does not mean is that nobody on these drugs becomes depressed. Depression is common. It is more common in people with obesity than in the general population, so this cohort starts with an elevated baseline. And a year of rapid change is a plausible trigger for anyone.

So the practical position is: the drug is unlikely to be causing it, and the symptom still needs taking seriously on its own terms.

Seek help promptly for: persistent low mood lasting more than 2 weeks, loss of interest in things unrelated to food, hopelessness, or any thoughts of harming yourself. If you have thoughts of suicide, contact your clinician, an emergency service, or a crisis line today. Do not wait for a scheduled appointment, and do not stop the medication and see how it goes as a substitute for being assessed.

If you have a history of an eating disorder

This warrants its own paragraph, because it is where I am most cautious.

These medications reliably produce the exact states that restrictive eating disorders treat as success: very low intake, rapid weight loss, indifference to food, a shrinking body. If you have a history of anorexia, bulimia, or a restrictive pattern that was never formally diagnosed, this class can be genuinely destabilising, and it can make relapse harder to see from the inside because everything it does looks like the treatment working.

That does not make it automatically inappropriate. Some people with a history do well with monitoring in place. It does mean the decision belongs in a conversation involving whoever treated you, before starting — not in a telehealth intake form. The same applies to binge eating disorder, where the picture is different and often more favourable, and still worth discussing.

I have written about my own version of this in sleep, mood, and the question I get asked most.

If you take psychiatric medication there is a further layer, because several of the most effective drugs in psychiatry cause substantial weight gain — GLP-1s and psychiatric medications.

What actually helps

Eat enough. The single most common reversible cause of flatness on this drug is not eating enough of anything, protein especially. If you are at 700 calories a day in month four, that is a problem to solve rather than an achievement.

Replace the function, not the food. Food was doing something. Something else has to. This is unglamorous and it is the actual work: walking, company, a project, anything that reliably occupies an evening.

Keep the training. Resistance training does two things at once here, and its effect on mood is well evidenced independent of anything about weight — see muscle is the whole game.

Tell someone. This is the effect people are least likely to report, because it sounds ungrateful when the treatment is working. It is not ungrateful. It is clinically relevant information and your prescriber needs it.

Watch the identity question. Losing 15–20% of your body weight over 12 months changes how the world treats you, and not always in ways that feel good. People who were invisible become visible; people comment on your body as though that were now permitted. Nobody schedules a conversation about that, and it is often what is actually bothering someone who arrives saying they feel flat.

The honest summary

The quiet is real and for many people it is the best part. The flatness is real too, it is common enough to be worth expecting around month 4, and it is usually manageable once it has been named.

The drug is not, on current evidence, causing depression. But it is not a reason to ignore depression either, and the line between “this is an adjustment” and “this is an illness” is one to draw with a clinician rather than alone.